Hypoxia-activated pro-drugs of the KDAC inhibitor vorinostat (SAHA)
Hypoxia (lower than normal oxygen) is a characteristic of most solid tumours that results in poor cancer patient prognosis. The difference in cellular environment between normoxia (21% oxygen) or physoxia (4–7.5% oxygen) and hypoxia (<2.0% oxygen) causes increased resistance to radio- and chemoth...
Main Authors: | Calder, EDD, Skwarska, A, Sneddon, D, Folkes, LK, Mistry, IN, Conway, SJ, Hammond, EM |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Elsevier
2020
|
Similar Items
-
Zap-Pano: a photocaged prodrug of the KDAC inhibitor panobinostat
by: Troelsen, KS, et al.
Published: (2021) -
Development and pre-clinical testing of a novel hypoxia-activated KDAC inhibitor
by: Skwarska, A, et al.
Published: (2021) -
Synergistic effects of vorinostat (SAHA) and azoles against Aspergillus species and their biofilms
by: Bo Tu, et al.
Published: (2020-02-01) -
Targeting Lysine Deacetylases (KDACs) in Parasites.
by: Qi Wang, et al.
Published: (2015-01-01) -
A G-Quadruplex-Binding Small Molecule and the HDAC Inhibitor SAHA (Vorinostat) Act Synergistically in Gemcitabine-Sensitive and Resistant Pancreatic Cancer Cells
by: Ahmed Abdullah Ahmed, et al.
Published: (2020-11-01)